Skip to main content
Janet McGill, MD, Endocrinology, Saint Louis, MO, Barnes-Jewish Hospital

JanetBMcGillMDMA, FACE, FACP

Endocrinology Saint Louis, MO

Diabetes, Lipid Metabolism, Thyroid

Professor of Medicine, Washington University St Louis

Dr. McGill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McGill's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
  • Beaumont Hospital, Royal Oak
    Beaumont Hospital, Royal OakFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1985
  • Beaumont Health (Royal Oak)
    Beaumont Health (Royal Oak)Residency, Internal Medicine, 1980 - 1984
  • Michigan State University College of Human Medicine
    Michigan State University College of Human MedicineClass of 1979

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1985 - 2025
  • MI State Medical License
    MI State Medical License 1981 - 2003
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Outstanding Physician Clinician in Diabetes American Diabetes Association, 2022
  • America's Top Doctors Castle Connolly, 2007-2022
  • Excellence in Teaching Washington University, 2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes  
    Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
  • Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease  
    Kavita Juneja, Janet B McGill, Jing W Hughes, Garry S Tobin, C Rachel Kilpatrick, Diabetes Care

Lectures

  • New Strategies for Obesity Management: Risk Stratification & Long-term Weight Control 
    American Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
  • New Strategies for Obesity Management: Risk Stratification & Long-term Weight Control 
    American Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
  • Hot Topics in Internal Medicine - CME Getaways Las Vegas 
    CME Getaways, Las Vegas, Nevada - 9/28/2012

Authored Content

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020

Press Mentions

  • Finerenone plus SGLT2 Inhibition May Yield Additive CV, Kidney Benefits: FIGARO-DKD
    Finerenone plus SGLT2 Inhibition May Yield Additive CV, Kidney Benefits: FIGARO-DKDOctober 5th, 2021
  • Clinical Highlights: 15th Annual CMHC Live Online
    Clinical Highlights: 15th Annual CMHC Live OnlineOctober 29th, 2020
  • YOUR HEALTH: Can Type 2 Medicines Help Type 1 Diabetics?
    YOUR HEALTH: Can Type 2 Medicines Help Type 1 Diabetics?September 27th, 2019
  • Join now to see all

Grant Support

  • Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • The Dream StudyNational Center For Research Resources2004–2007
  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)National Center For Research Resources2005
  • Early Diabetes Intervention Program (EDIP)National Center For Research Resources1999–2005
  • Early Diabetes Intervention Program. (EDIP)National Center For Research Resources2004
  • Correlation Of 15ag To Established Glycemia Markers In DiabetesNational Center For Research Resources2004
  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d).National Center For Research Resources2004
  • Plant Sterols In Cholesterol AbsorptionNational Center For Research Resources2000–2002
  • Nabumetone, Celcoxib &Ibuprofen On Blood Pressure Control In HypertensionNational Center For Research Resources2000–2002
  • Inhaled Vs. Subcutaneous Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources2000–2002
  • Inhaled Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources2000–2002
  • Gi262570 Sodium Tablets W/ Metformin For 26 WKS In NIDDMNational Center For Research Resources2000–2002
  • Gi262570 Sodium Tablets Monotherapy For 26wks In NIDDMNational Center For Research Resources2000–2002
  • External Continuous Subcutaneous Insulin Aspart Infusion In NIDDMNational Center For Research Resources2000–2002
  • External Continuous Infusion Of Insulin Aspart, Lispro &Buffered Regular In IDDMNational Center For Research Resources2000–2002
  • Evaluation Of Multi Dose Regimen L-753,037 In African Americans With HypertensionNational Center For Research Resources2000–2002
  • Evaluate 3 Fixed Doses Of SDZ Djn 608 In NIDDMNational Center For Research Resources2000–2002
  • Effect Of A-100 On Glycemic Control In Overweight NIDDM Treated With MetforminNational Center For Research Resources2000–2002
  • Diabetes Center--Clinical Research Facility, Research, And TrainingNational Center For Research Resources2000–2002
  • Comparison Of Tcpi Td-Glucose With Finger Stick MethodsNational Center For Research Resources2000–2002
  • SDZ Djn 608 Monotherapy Compared To Glibenclamide Monotherapy B304 ENational Center For Research Resources1999–2002
  • Repaglinide And Troglitazone In Treatment Of Type II Diabetes MellitusNational Center For Research Resources1999–2002
  • Oral Gi262570x Monotherapy 12weeks Duration Subjects With Type2 DiabetesNational Center For Research Resources1999–2002
  • Metformin And Glyburide Combination Products In Diabetes PatientsNational Center For Research Resources1999–2002
  • Brl49653c Combination With Glyburide To Patients With DiabetesNational Center For Research Resources1999–2002
  • Brl49653 Combination With Insulin To Patients With Noninsulin Dependent DiabetesNational Center For Research Resources1999–2002
  • Antiproteinuric Effects Of Omapatrilat And Amlodipine In Type II DiabetesNational Center For Research Resources1999–2002
  • 52 Week, Orlistat Treatment In Obese Patients With Type 2 Diabetes MellitusNational Center For Research Resources1999–2002
  • Oral Zopolrestat In Subjects With Peripheral Symmetrical Diabetic PolyneuropathyNational Center For Research Resources1998–2002
  • 26 Weeks Of BRL 49653c Given 2X Day To Patients W/ NIDDM &Inadequate ControlNational Center For Research Resources1998–2002
  • Renal Protective Effects Of Losartan In Patients With NIDDM And NephropathyNational Center For Research Resources1997–2002
  • OPEN Label Long Term Tolerability Of Pioglitazone AD 48333 In NIDDM PatientsNational Center For Research Resources1997–2002
  • Oral Zololrestat In Normotensive, Type I Diabetics With Incipient NephropathyNational Center For Research Resources1996–2002
  • Diabetes Registry--Research And Education FacilityNational Center For Research Resources1996–2002
  • Oral Gi26257ox In Patients W Type II Diabetes MellitusNational Center For Research Resources1999
  • Randomized Study To Determine Effects Of Subcutaneous Recombinant LeptinNational Center For Research Resources1998–1999
  • PET Detection Of The Diabetic HeartNational Center For Research Resources1998–1999
  • Intra And Intersubject Variability In Absorption Of Subcutaneous InsulinNational Center For Research Resources1998–1999
  • Human Insulin Analogue X14 &Regular Human Insulin As Meal Related InsulinNational Center For Research Resources1998–1999
  • Evaluation Of Dose Ranges Of SC 6610 In Treatment Of HypertensionNational Center For Research Resources1998–1999
  • Evaluate Safety, Efficacy And Tolerability Of 3 Fixed Doses Of SDZ Djn 608National Center For Research Resources1998–1999
  • Effects Of Subcutaneous Admin Of Insulin &Rhigf 1 In Subjects With IDDMNational Center For Research Resources1998–1999
  • BRL 49653c Admin 1X Day To PTS W/ NIDDM Inadequately Controlled On GlyburideNational Center For Research Resources1998–1999
  • 28 Week OPEN Clinical Trial Comparing HOE 901 Insulin With NPH Human InsulinNational Center For Research Resources1998–1999
  • 16 Week Multicenter Clinical Trial Comparing H0e901 W/ NPH Human InsulinNational Center For Research Resources1998–1999
  • Venlafaxine ER Capsules For Chronic Pain Associated With Diabetic NeuropathyNational Center For Research Resources1997–1999
  • Tolerability Of Pramlintide In Patients With Type I DiabetesNational Center For Research Resources1997–1999
  • Telmisartan As Monotherapy Or In Combination With Other Antihypertensive DrugsNational Center For Research Resources1997–1999
  • Sucralose Versus Placebo On Glucose Homeostasis In NIDDM SubjectsNational Center For Research Resources1997–1999
  • Oral Ana756 In Treatment Of Patients With Essential HypertensionNational Center For Research Resources1997–1999
  • Pimagedine In Patients With Type II Diabetes Mellitus And Diabetic NephropathyNational Center For Research Resources1996–1999
  • Efect Of Ac137 On Plasma Glucose Profiles In Patients With Type II DiabetesNational Center For Research Resources1996–1999
  • Aminoguanidine In Diabetic Patients With Overt Diabetic NephropathyNational Center For Research Resources1996–1999
  • Two Formulations Of HOE 901 Insulin In Comparison To NPH Insulin In NIDDMNational Center For Research Resources1997
  • Telmisartan And Hctz In Patients With Mild To Moderate Essential HypertensionNational Center For Research Resources1997
  • Oral Zopolrestat In Subjects With Peripheral Symmetical Diabetic PolyneuropathyNational Center For Research Resources1997
  • Orlistat In The Treatment Of Obese Subjects With NIDDMNational Center For Research Resources1996–1997
  • Miglitol As Compared To A Fixed Dose Of Sulfonylurea In The Treatment Of NIDDMNational Center For Research Resources1996–1997
  • Metformin Hydrochloride In Patients With Noninsulin Dependent Diabetes MellitusNational Center For Research Resources1996–1997
  • Ci-991 In NIDDM To Assess Potential Effects On Cardiac Mass And FunctionNational Center For Research Resources1996–1997
  • Angiotensin Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources1996–1997
  • U-98079a (DAV6215CL) Capsules In The Treatment Of Mixed Anxiety And DepressionNational Center For Research Resources1996
  • Triproamylin On Glucose Profile And Pharmacokinetics In Juvenile Onset DiabetesNational Center For Research Resources1996
  • Oral Dose Levels Of Rs-15385-197 In Men With Erectile DisorderNational Center For Research Resources1996
  • Occlusions Of Insulin Delivery In Continuous Subcutaneous Insulin Infusion (HumanNational Center For Research Resources1990
  • Multicenter Clinical Trial Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources1990
  • Energy Metabolism During AnesthesiaNational Center For Research Resources1990
  • Effect Of Captopril On Microalbuminia/Insulin Dependent Diabetes MellitusNational Center For Research Resources1990

Committees

  • member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2033
  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015

Professional Memberships

Hospital Affiliations